Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure

The study is a prospective, non-randomized, single-arm, multi-center, feasibility study. The Supira System is a minimally invasive, percutaneous ventricular assist device (pVAD) that is intended to provide hemodynamic support to patients undergoing high risk percutaneous coronary intervention (HRPCI) and requiring hemodynamic support. The Catheter is inserted percutaneously, across the aortic valve, and into the left ventricle under fluoroscopic guidance. The left ventricle is unloaded by pumping blood from the ventricle into the ascending aorta and systemic circulation.